Details of the Drug

General Information of Drug (ID: DMGDZLP)

• Drug Name: US10022354, Example 152
• Synonyms: CHEMBL4059597; SCHEMBL17682668; BDBM281212; US10022354, Example 152
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 304.39
  Logarithm of the Partition Coefficient (xlogp); 1.7
  Rotatable Bond Count (rotbonds); 4
  Hydrogen Bond Donor Count (hbonddonor); 2
  Hydrogen Bond Acceptor Count (hbondacc); 3
• Chemical Identifiers:
  Formula: C16H24N4O2
  IUPAC Name: N-[1-(5-propan-2-yl-1H-pyrazole-3-carbonyl)pyrrolidin-3-yl]cyclobutanecarboxamide
  Canonical SMILES: CC(C)C1=CC(=NN1)C(=O)N2CCC(C2)NC(=O)C3CCC3
  InChI: InChI=1S/C16H24N4O2/c1-10(2)13-8-14(19-18-13)16(22)20-7-6-12(9-20)17-15(21)11-4-3-5-11/h8,10-12H,3-7,9H2,1-2H3,(H,17,21)(H,18,19)
  InChIKey: WFZQSICPYNAMNU-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 121279737
  TTD ID: D0T8YT

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lysine-specific demethylase 5A (KDM5A)	TTIG67W	KDM5A_HUMAN	Inhibitor	[1]

References

• [1] IRE-1 inhibitors